Balaxi Pharmaceuticals Ltd is an IPR-based pharmaceutical Company engaged in producing, stocking, selling, and supplying branded and generic medicines.
Financial Results:
Balaxi Pharmaceuticals Ltd reported Revenues for Q1FY24 of ₹66.00 Crores down from ₹83.00 Crore year on year, a fall of 20.48%.
Total Expenses for Q1FY24 of ₹57.00 Crores down from ₹69.00 Crores year on year, a fall of 17.39%.
Consolidated Net Profit of -₹41.00 Crores from ₹14.00 Crores in the same quarter of the previous year.
The Earnings per Share is -₹40.41, from ₹14.15 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.